نتائج البحث - "Vlachopoulos C."

1

دورية أكاديمية

Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Arterial Hypertension of the Hellenic Society of Cardiology.

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://openaccess.sgul.ac.uk/id/eprint/116211/1/1-s2.0-S1109966623001458-main.pdfTest; https://openaccess.sgul.ac.uk/id/eprint/116211/7/1-s2.0-S1109966623001458-mmc1.docxTest; https://openaccess.sgul.ac.uk/id/eprint/116211/9/1-s2.0-S1109966623001458-mmc2.docxTest; Kallistratos, M; Konstantinidis, D; Dimitriadis, K; Sanidas, E; Katsi, V; Androulakis, E; Vlachopoulos, C; Toutouzas, K; Kanakakis, J; Sideris, S; et al. Kallistratos, M; Konstantinidis, D; Dimitriadis, K; Sanidas, E; Katsi, V; Androulakis, E; Vlachopoulos, C; Toutouzas, K; Kanakakis, J; Sideris, S; Kafkas, N; Mavrogianni, AD; Papadopoulos, CH; Stefanidis, A; Patsourakos, N; Kachrimanidis, I; Papaioannou, N; Tsioufis, C; Kochiadakis, G; Marketou, M (2024) Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Arterial Hypertension of the Hellenic Society of Cardiology. Hellenic J Cardiol, 75. pp. 82-92. ISSN 2241-5955 https://doi.org/10.1016/j.hjc.2023.08.008Test SGUL Authors: Androulakis, Emmanouil

الإتاحة: https://doi.org/10.1016/j.hjc.2023.08.008Test
https://openaccess.sgul.ac.uk/id/eprint/116211Test/
https://openaccess.sgul.ac.uk/id/eprint/116211/1/1-s2.0-S1109966623001458-main.pdfTest
https://openaccess.sgul.ac.uk/id/eprint/116211/7/1-s2.0-S1109966623001458-mmc1.docxTest
https://openaccess.sgul.ac.uk/id/eprint/116211/9/1-s2.0-S1109966623001458-mmc2.docxTest

View record in BASE

2

دورية أكاديمية

Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study

المؤلفون: Vlachopoulos, C., Massia, D., Kochiadakis, G., Kolovou, G., Patsilinakos, S., Bridges, I., Sibartie, M., Dhalwani, N.N., Liberopoulos, E., Ray, K.K.

المساهمون: Amgen

المصدر: Hellenic Journal of Cardiology ; volume 74, page 74-76 ; ISSN 1109-9666

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الإتاحة: https://doi.org/10.1016/j.hjc.2023.09.003Test
https://api.elsevier.com/content/article/PII:S1109966623001537?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1109966623001537?httpAccept=text/plainTest

View record in BASE

3

دورية أكاديمية

Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023

المصدر: Atherosclerosis Plus ; volume 55, page 74-92 ; ISSN 2667-0895

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine, Internal Medicine

الإتاحة: https://doi.org/10.1016/j.athplu.2024.01.004Test
https://api.elsevier.com/content/article/PII:S266708952400004X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S266708952400004X?httpAccept=text/plainTest

View record in BASE

4

دورية أكاديمية

Implications of ACC/AHA Versus ESC/EAS LDL-C recommendations for residual risk reduction in ASCVD: a simulation study from DA VINCI

المؤلفون: Vallejo-Vaz, AJ, Bray, S, Villa, G, Brandts, J, Kiru, G, Murphy, J, Banach, M, De Servi, S, Gaita, D, Gouni-Berthold, I, Hovingh, GK, Jozwiak, JJ, Jukema, JW, Kiss, RG, Kownator, S, Iversen, HK, Maher, V, Masana, L, Parkhomenko, A, Peeters, A, Clifford, P, Raslova, K, Siostrzonek, P, Romeo, S, Tousoulis, D, Vlachopoulos, C, Vrablik, M, Catapano, AL, Poulter, NR, Ray, KK

المصدر: 953 ; 941

العلاقة: Cardiovascular Drugs and Therapy; http://hdl.handle.net/10044/1/97688Test

الإتاحة: https://doi.org/10.1007/s10557-022-07343-xTest
http://hdl.handle.net/10044/1/97688Test

View record in BASE

5

دورية أكاديمية

Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

المؤلفون: Banach M, Penson PE, Vrablik M, Bunc M, Dyrbus K, Fedacko J, Gaita D, Gierlotka M, Jarai Z, Magda SL, Margetic E, Margoczy R, Durak-Nalbantic A, Ostadal P, Pella D, Trbusic M, Udroiu CA, Vlachopoulos C, Vulic D, Fras Z, Dudek D, Reiner Ž, ACS EuroPath Central &, South European Countries Project, Cicero AFG.

المساهمون: Banach M, Penson PE, Vrablik M, Bunc M, Dyrbus K, Fedacko J, Gaita D, Gierlotka M, Jarai Z, Magda SL, Margetic E, Margoczy R, Durak-Nalbantic A, Ostadal P, Pella D, Trbusic M, Udroiu CA, Vlachopoulos C, Vulic D, Fras Z, Dudek D, Reiner Ž, ACS EuroPath Central & South European Countries Project, Cicero AFG.

مصطلحات موضوعية: Combination therapy, Effectivene, Ezetimibe, PCSK9 inhibitor, Safety, Statins

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33607265; info:eu-repo/semantics/altIdentifier/wos/WOS:000643656100028; volume:166; firstpage:1; lastpage:12; numberofpages:12; journal:PHARMACOLOGICAL RESEARCH; https://hdl.handle.net/11585/853229Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101832989; https://pubmed-ncbi-nlm-nih-gov.ezproxy.unibo.it/33607265Test/; https://www.sciencedirect.com/science/article/pii/S1043661821000839Test

الإتاحة: https://doi.org/10.1016/j.phrs.2021.105499Test
https://hdl.handle.net/11585/853229Test
https://pubmed-ncbi-nlm-nih-gov.ezproxy.unibo.it/33607265Test/
https://www.sciencedirect.com/science/article/pii/S1043661821000839Test

View record in BASE

6

دورية أكاديمية

OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

المؤلفون: Banach, M, Penson, PE, Vrablik, M, Bunc, M, Dyrbus, K, Fedacko, J, Gaita, D, Gierlotka, M, Jarai, Z, Magda, SL, Margetic, E, Margoczy, R, Durak-Nalbantic, A, Ostadal, P, Pella, D, Trbusic, M, Udroiu, CA, Vlachopoulos, C, Vulic, D, Fras, Z, Dudek, D, Reiner, Ž

مصطلحات موضوعية: RM Therapeutics. Pharmacology

وصف الملف: text

العلاقة: https://researchonline.ljmu.ac.uk/id/eprint/14494/1/OPTIMAL%20USE%20OF%20LIPID-LOWERING%20THERAPY%20AFTER%20ACUTE%20CORONARY%20SYNDROMES.pdfTest; Banach, M, Penson, PE, Vrablik, M, Bunc, M, Dyrbus, K, Fedacko, J, Gaita, D, Gierlotka, M, Jarai, Z, Magda, SL, Margetic, E, Margoczy, R, Durak-Nalbantic, A, Ostadal, P, Pella, D, Trbusic, M, Udroiu, CA, Vlachopoulos, C, Vulic, D, Fras, Z, Dudek, D and Reiner, Ž (2021) OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). Pharmacological Research. ISSN 1043-6618

الإتاحة: https://doi.org/10.1016/j.phrs.2021.105499Test
http://researchonline.ljmu.ac.uk/id/eprint/14494Test/
https://researchonline.ljmu.ac.uk/id/eprint/14494/1/OPTIMAL%20USE%20OF%20LIPID-LOWERING%20THERAPY%20AFTER%20ACUTE%20CORONARY%20SYNDROMES.pdfTest

View record in BASE